Any new molecular compound (excluding diagnostic agents, vaccines, and other biologic compounds) not previously approved for human use by CDER.
Glossary
New Chemical Entity (NCE)
02.27.12
-
Breaking News | Industry News
Lonza Completes Divestment of Sites to NextPharma
Lonza exits both softgels and liquid-filled hard capsules and NextPharma plans to broaden its technology offering into lipid based finished dosage forms.Kristin Brooks
-
Breaking News | Collaborations & Alliances | Industry News | Parenterals
LipoMedix, ForDoz Enter Manufacturing Agreement
Lead compound Promitil will be manufactured in the U.S. by ForDoz.Tim Wright, Editor, Contract Pharma
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru
Combines Stelis' bioprocess development capabilities with Merck's bioprocessing equipment
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Preclinical Outsourcing
Sanofi and Exscientia Pen €250M Drug Discovery Deal
Initiates collaboration to develop bispecific-small-molecule drugs
